New Pancreatic Cancer Pill Shows Promise in Clinical Trials
A new pancreatic cancer treatment has shown promising results in early clinical trials. The experimental drug daraxonrasib has demonstrated the ability to nearly double survival time for patients, representing a potential advancement in treating this difficult-to-manage disease.
The drug works by targeting a specific protein that drives cancer